Butler, C., Hobbs, F., Gbinigie, O., Rahman, N., Hayward, G., Richards, D., Dorward, J., Lowe, D., Standing, J., Breuer, J., Khoo, S., Petrou, S., Hood, K., Nguyen-Van-Tam, J., Patel, M., Saville, B., Marion, J., Ogburn, E., Allen, J., Rutter, H., Francis, N., Thomas, N., Evans, P., Dobson, M., Madden, T., Holmes, J., Harris, V., Png, M., Lown, M., van Hecke, O., Detry, M., Saunders, C., Fitzgerald, M., Berry, N., Mwandigha, L., Galal, U., Mort, S., Jani, B., Hart, N., Ahmed, H., Butler, D., McKenna, M., Chalk, J., Lavallee, L., Hadley, E., Cureton, L., Benysek, M., Andersson, M., Coates, M., Barrett, S., Bateman, C., Davies, J., Raymundo-Wood, I., Ustianowski, A., Carson-Stevens, A., Yu, L., Little, P., Agyeman, A., Ahmed, T., Allcock, D., Beltran-Martinez, A., Benedict, O., Bird, N., Brennan, L., Brown, J., Burns, G., Butler, M., Cheng, Z., Danson, R., de Kare-Silver, N., Dhasmana, D., Dickson, J., Engamba, S., Fisher, S., Fox, R., Frost, E., Gaunt, R., Ghosh, S., Gilkar, I., Goodman, A., Granier, S., Howell, A., Hussain, I., Hutchinson, S., Imlach, M., Irving, G., Jacobsen, N., Kennard, J., Khan, U., Knox, K., Krasucki, C., Law, T., Lee, R., Lester, N., Lewis, D., Lunn, J., Mackintosh, C., Mathukia, M., Moore, P., Morton, S., Murphy, D., Nally, R., Ndukauba, C., Ogundapo, O., Okeke, H., Patel, A., Patel, K., Penfold, R., Poonian, S., Popoola, O., Pora, A., Prasad, V., Prasad, R., Razzaq, O., Richardson, S., Royal, S., Safa, A., Sehdev, S., Sevenoaks, T., Shah, D., Sheikh, A., Short, V., Sidhu, B., Singh, I., Soni, Y., Thalasselis, C., Wilson, P., Wingfield, D., Wong, M., Woodall, M., Wooding, N., Woods, S., Yong, J., Yongblah, F. & Zafar, A. 2022, 'Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial', The Lancet, 401(10373), pp. 281-293. http://dx.doi.org/10.1016/S0140-6736(22)02597-1